Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses

19. oktober 2026 oppdatert av: CooperVision, Inc.

En klinisk utprøving av Comfilcon A Extended Range multifokale linser

The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.

Studieoversikt

Detaljert beskrivelse

This study is a 13-subject, randomized, prospective, single site, daily wear, single-masked (to the subject), bilateral, 4-day cross-over, dispensing study comparing the comfilcon A extended range multifocal test lens against the comfilcon A multifocal control lens.

Studietype

Intervensjonell

Registrering (Faktiske)

14

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Indiana
      • Bloomington, Indiana, Forente stater, 47405
        • CORL, Indiana University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

50 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

A person is eligible for inclusion in the study if he/she:

  • Has had a self-reported oculo-visual examination in the last two years
  • Is 50 years of age or greater and has full legal capacity to volunteer
  • Is able to read and understand the informed consent
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Has a spherical distance contact lens prescription between -1.00 and -5.00D (Diopters) (inclusive)
  • Near Add Power requirement of +2.25D or greater
  • Has spectacle cylinder 0.75 D in both eyes
  • Has normal binocularity (no amblyopia, no strabismus, no habitually uncorrected anisometropia ≥ 2.00D)
  • Has monocular best-corrected distance visual acuity of 20/30 or better in each eye
  • Has clear corneas and no active ocular disease
  • Has not worn gas permeable contact lenses for 1 month prior to the study

Exclusion Criteria:

A person will be excluded from the study if he/she:

  • Has never worn contact lenses before
  • Has any systemic disease affecting ocular health
  • Is using any systemic or topical medications that will affect ocular health
  • Has any ocular pathology or abnormality that would affect the wearing of contact lenses
  • Is aphakic (i.e. missing their natural lens inside their eye)
  • Has uncorrected anisometropia (i.e. difference in the prescription between the eyes) of ≥2.00 D
  • Has undergone corneal refractive surgery
  • Is participating in any other type of eye related clinical or research study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: comfilcon A Extended Range test lens

Subjects will be randomized to wear either the test or control pair of lens, then cross over to the alternate pair.

contact lens

contact lens

Aktiv komparator: comfilcon A control lens

Subjects will be randomized to wear either the test or control pair of lens, then cross over to the alternate pair.

contact lens

contact lens

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Visual Acuity
Tidsramme: 4 days

Visual acuity was measured at distance, intermediate and near conditions for test and control lens was assessed by LogMAR.

4 days
Visual Performance
Tidsramme: 4 days

Subjective assessment of visual performance for test and control lens is assessed on a scale 0-100, 0=extremely poor vision all of the time and cannot function, 100= excellent vision all of the time).

4 days

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Subjective Ratings for Comfort
Tidsramme: Baseline

Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).

Baseline
Subjective Ratings for Comfort
Tidsramme: 4 days

Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).

4 days
Subjective Ratings for Dryness
Tidsramme: Baseline

Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).

Baseline
Subjective Ratings for Dryness
Tidsramme: 4 days

Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).

4 days
Lens Handling
Tidsramme: 4 Days

Subjective ratings for handling (ease of insertion and removal) was assessed for test and control lens on a scale 0-100, 0=very difficult to handle, 100=easy to handle).

4 Days
Average Daily Wearing Time
Tidsramme: 4 days

Average daily wearing time for test and control lens is assessed in hours.

4 days
Lens Fit
Tidsramme: 4 days

Lens fit acceptance (general fit characteristics) is assessed for test and control lens on a 0-4 grading system in 0.25 steps where 0 represented very poor fit.

4 days
Bulbar Hyperemia
Tidsramme: 4 days

Bulbar hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.

4 days
Limbal Hyperemia
Tidsramme: 4 days

Limbal hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.

4 days
Subjective Satisfaction
Tidsramme: 4 days

Subjective satisfaction for test and control lens was assessed on a scale 0-100, 0=extremely dissatisfied, 100=very satisfied)

4 days
Subjective Preference for Near Vision
Tidsramme: 4 days

Subjective preference for near vision for test and control contact lenses. comfort, vision, handling, satisfaction.

4 days
Subjective Preference for Distance Vision
Tidsramme: 4 days

Subjective preference for distance vision for test and control contact lenses.

4 days
Subjective Preference for Intermediate Vision
Tidsramme: 4 days

Subjective preference for intermediate vision for test and control contact lenses.

4 days
Subjective Preference for Overall Vision
Tidsramme: 4 days

Subjective preference for overall vision for test and control contact lenses.

4 days
Subjective Preference for Comfort
Tidsramme: 4 days

Subjective preference for comfort for test and control contact lenses.

4 days
Subjective Overall Lens Preference
Tidsramme: 4 days

Subjective overall lens preference for test and control contact lenses.

4 days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Pete S Kollbaum, O.D., Indiana University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mars 2016

Primær fullføring (Faktiske)

1. mai 2016

Studiet fullført (Faktiske)

1. august 2016

Datoer for studieregistrering

Først innsendt

21. mars 2016

Først innsendt som oppfylte QC-kriteriene

21. mars 2016

Først lagt ut (Antatt)

25. mars 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

3. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • CV-16-02

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere